{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:53:51Z","timestamp":1781704431945,"version":"3.54.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10787-026-02273-8","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:25:57Z","timestamp":1779535557000},"page":"4065-4074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6783","authenticated-orcid":false,"given":"Francesco","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"2273_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1525-1470.2009.00980.x","volume":"26","author":"N Al-Mutairi","year":"2009","unstructured":"Al-Mutairi N (2009) 308-nm excimer laser for the treatment of Alopecia areata in children. Pediatr Dermatol 26:547\u2013550","journal-title":"Pediatr Dermatol"},{"key":"2273_CR2","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1111\/pde.13699","volume":"36","author":"A Aleisa","year":"2019","unstructured":"Aleisa A, Lim Y, Gordon S et al (2019) Response to ustekinumab in three pediatric patients with Alopecia areata. Pediatr Dermatol 36:e44\u2013e45","journal-title":"Pediatr Dermatol"},{"key":"2273_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000494613","volume":"235","author":"N Almutairi","year":"2019","unstructured":"Almutairi N, Nour TM, Hussain NH (2019) Janus kinase inhibitors for the treatment of severe Alopecia areata: an open-label comparative study. Dermatology 235:130\u2013136","journal-title":"Dermatology"},{"key":"2273_CR4","doi-asserted-by":"publisher","first-page":"e0164080","DOI":"10.1371\/journal.pone.0164080","volume":"11","author":"AK Alves de Medeiros","year":"2016","unstructured":"Alves de Medeiros AK, Speeckaert R, Desmet E, van Gele M, de Schepper S, Lambert J (2016) JAK3 as an emerging target for topical treatment of inflammatory skin diseases. PLoS ONE 11:e0164080","journal-title":"PLoS ONE"},{"key":"2273_CR5","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258\u2013J265","journal-title":"J Autoimmun"},{"key":"2273_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jaad.2021.04.077","volume":"86","author":"VR Barton","year":"2022","unstructured":"Barton VR, Toussi A, Awasthi S, Kiuru M (2022) Treatment of pediatric Alopecia areata: a systematic review. J Am Acad Dermatol 86:1318\u20131334","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR7","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jaad.2021.04.077","volume":"86","author":"VR Barton","year":"2022","unstructured":"Barton VR, Toussi A, Awasthi S, Kiuru M (2022) Treatment of pediatric Alopecia areata: a systematic review. J Am Acad Dermatol 86:1318\u20131334","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR8","doi-asserted-by":"crossref","unstructured":"Bose P, Verstovsek S JAK2 inhibitors for myeloproliferative neo plasms: what is next? Blood; 130: 115\u2009\u2013\u200925","DOI":"10.1182\/blood-2017-04-742288"},{"key":"2273_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2340\/000155555493496","volume":"55","author":"JL Burton","year":"1975","unstructured":"Burton JL, Shuster S (1975) Large doses of glucocorticoid in the treatment of Alopecia areata. Acta Derm Venereol 55:493\u2013496","journal-title":"Acta Derm Venereol"},{"key":"2273_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.annder.2010.06.031","volume":"137","author":"E Chartaux","year":"2010","unstructured":"Chartaux E, Jolly P (2010) Long-term follow-up of the efficacy of methotrexate alone or in combination with low dose of oral corticosteroids in the treatment of Alopecia totalis or universalis. Ann Dermatol Venereol 137:507\u2013513","journal-title":"Ann Dermatol Venereol"},{"key":"2273_CR11","unstructured":"ClinicalTrials.gov PF-06651600 for the treatment of Alopecia areata (ALLEGRO-2b\/3). Disponibile su: https:\/\/lc.cx\/dzkaEI [ultimo accesso 21 ottobre 2024]"},{"issue":"5 Pt 1","key":"2273_CR12","first-page":"757","volume":"33","author":"BW Colombe","year":"1995","unstructured":"Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD (1995) HL A class II antigen associations help to define two types of Alopecia areata. J Am Acad Dermatol 33(5 Pt 1):757\u2013764","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ajd.12941","volume":"60","author":"WC Cranwell","year":"2019","unstructured":"Cranwell WC, Lai VW, Photiou L et al (2019) Treatment of alopecia areata: an Australian expert consensus statement. Australas J Dermatol 60:163\u2013170","journal-title":"Australas J Dermatol"},{"key":"2273_CR14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky W, King BA (2017) JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol 76:736\u2013744","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/0019-5154.62747","volume":"55","author":"S Das","year":"2010","unstructured":"Das S, Ghorami RC, Chatterjee T, Banerjee G (2010) Comparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in Alopecia areata. Indian J Dermatol 55:148\u2013149","journal-title":"Indian J Dermatol"},{"key":"2273_CR16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","volume":"77","author":"S Dhillon","year":"2017","unstructured":"Dhillon S (2017) Tofacitinib: a review in rheumatoid arthritis. Drugs 77:1987\u20132001","journal-title":"Drugs"},{"key":"2273_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3685","volume":"20","author":"SJ Divito","year":"2014","unstructured":"Divito SJ, Kupper TS (2014) Inhibiting Janus kinases to treat Alopecia areata. Nat Med 20:989\u2013990","journal-title":"Nat Med"},{"key":"2273_CR18","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","volume":"49","author":"S Farshi","year":"2010","unstructured":"Farshi S, Mansouri P, Safar F, Khiabanloo SR (2010) Could azathioprine be considered as a therapeutic alternative in the treatment of Alopecia areata? A pilot study. Int J Dermatol 49:1188\u20131193","journal-title":"Int J Dermatol"},{"key":"2273_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/bmj.287.6398.1015","volume":"287","author":"DA Fenton","year":"1983","unstructured":"Fenton DA, Wilkinson JD (1983) Topical minoxidil in the treatment of Alopecia areata. Br Med J (Clin Res Ed) 287:1015\u20131017","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2273_CR20","doi-asserted-by":"publisher","first-page":"69S","DOI":"10.1111\/1523-1747.ep12471880","volume":"96","author":"VC Fiedler","year":"1991","unstructured":"Fiedler VC (1991) Alopecia areata: current therapy. J Invest Dermatol 96:69S\u201370S","journal-title":"J Invest Dermatol"},{"key":"2273_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1346-8138.16207","volume":"49","author":"M Fukuyama","year":"2021","unstructured":"Fukuyama M, Ito T, Ohyama M (2021) Alopecia areata: current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines. J Dermatol 49:19\u201336","journal-title":"J Dermatol"},{"issue":"4","key":"2273_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40257-023-00799-z","volume":"24","author":"S Fung","year":"2023","unstructured":"Fung S, Shirley M, Baricitinib (2023) A Review in Severe Alopecia Areata. Am J Clin Dermatol 24(4):661\u2013668. https:\/\/doi.org\/10.1007\/s40257-023-00799-z","journal-title":"Am J Clin Dermatol"},{"key":"2273_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4103\/0378-6323.110767","volume":"79","author":"S Ganjoo","year":"2013","unstructured":"Ganjoo S, Thappa DM (2013) Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of Alopecia areata. Indian J Dermatol Venereol Leprol 79:408\u2013417","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2273_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jdv.15937","volume":"34","author":"L Guo","year":"2020","unstructured":"Guo L, Feng S, Sun B, Jiang X, Liu Y (2020) Benefit and risk profile of Tofacitinib for the treatment of Alopecia areata: a systemic review and meta-analysis. J Eur Acad Dermatol Venereol 34:192\u2013201","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2273_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4103\/ijd.IJD_481_16","volume":"64","author":"P Gupta","year":"2019","unstructured":"Gupta P, Verma KK, Khandpur S, Bhari N (2019) Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe Alopecia areata. Indian J Dermatol 64:292\u2013298","journal-title":"Indian J Dermatol"},{"key":"2273_CR26","doi-asserted-by":"publisher","first-page":"e1500973","DOI":"10.1126\/sciadv.1500973","volume":"1","author":"S Harel","year":"2015","unstructured":"Harel S, Higgins CA, Cerise JE et al (2015) Pharmacologic inhibition of JAK-STAT signaling promotes hair growth. Sci Adv 1:e1500973","journal-title":"Sci Adv"},{"key":"2273_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0733-8635(05)70400-9","volume":"14","author":"R Hoffmann","year":"1996","unstructured":"Hoffmann R, Happle R (1996) Topical immunotherapy in Alopecia areata. What, how, and why? Dermatol Clin 14:739\u2013744","journal-title":"Dermatol Clin"},{"key":"2273_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1529-8019.2011.01421.x","volume":"24","author":"MK Hordinsky","year":"2011","unstructured":"Hordinsky MK (2011) Treatment of Alopecia areata: What is new on the horizon? Dermatol Ther 24:364\u2013368","journal-title":"Dermatol Ther"},{"key":"2273_CR29","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1080\/09546634.2021.1886230","volume":"33","author":"H Husein-El Ahmed","year":"2022","unstructured":"Husein-El Ahmed H, Steinhoff M (2022) Efficacy and predictive factors of cyclosporine A in Alopecia areata: a systematic review with meta-analysis. J Dermatolog Treat 33:1643\u20131651","journal-title":"J Dermatolog Treat"},{"key":"2273_CR30","doi-asserted-by":"publisher","unstructured":"Ibba L, Gargiulo L, Bianco M, Di Giulio S, Cascio Ingurgio R, Alfano A, Vignoli CA, Valenti M, Facheris P, Perugini C, Narcisi A, Costanzo A (2025) Potential role of leptin in Janus kinase 2 inhibitor-associated weight gain: a monocentric retrospective study. Clin Exp Dermatol. ;50(9):1834\u20131837. https:\/\/doi.org\/10.1093\/ced\/llaf144. PMID: 40172062","DOI":"10.1093\/ced\/llaf144"},{"key":"2273_CR31","doi-asserted-by":"publisher","first-page":"e13010","DOI":"10.1111\/dth.13010","volume":"32","author":"SA Ibrahim","year":"2019","unstructured":"Ibrahim SA, Esawy AM, Abdelshafy AS (2019) Treatment of chronic extensive Alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin. Dermatol Ther 32:e13010","journal-title":"Dermatol Ther"},{"key":"2273_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1346-8138.2009.00647.x","volume":"36","author":"S Inui","year":"2009","unstructured":"Inui S, Nakajima T, Toda N, Itami S (2009) Fexofenadine hydro-chloride enhances the efficacy of contact immunotherapy for extensive Alopecia areata: Retrospective analysis of 121 cases. J Dermatol 36:323\u2013327","journal-title":"J Dermatol"},{"key":"2273_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","volume":"69","author":"T Ito","year":"2013","unstructured":"Ito T, Hashizume H, Shimauchi T et al (2013) CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of Alopecia areata followed by sustained Tc1 accumulation in the chronic phase. J Dermatol Sci 69:140\u2013147","journal-title":"J Dermatol Sci"},{"key":"2273_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0165-1218(80)90030-0","volume":"78","author":"DR Jagannath","year":"1980","unstructured":"Jagannath DR, D\u2019Addario AP, Brusick DJ (1980) Mutagenic activity of 1-fluoro-2,4- dinitrobenzene in the Ames test. Mutat Res 78:91\u201395","journal-title":"Mutat Res"},{"key":"2273_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/1346-8138.13613","volume":"44","author":"M Jun","year":"2017","unstructured":"Jun M, Lee NR, Lee WS (2017) Efficacy and safety of superficial cryotherapy for Alopecia areata: a retrospective, comprehensive review of 353 cases over 22 years. J Dermatol 44:386\u2013393","journal-title":"J Dermatol"},{"key":"2273_CR36","first-page":"e404","volume":"115","author":"KJ Ju\u00e1rez-Rend\u00f3n","year":"2017","unstructured":"Ju\u00e1rez-Rend\u00f3n KJ, Rivera S\u00e1nchez G, Reyes-L\u00f3pez M\u00c1 et al (2017) Alopecia areata. Current situation and perspectives. Arch Argent Pediatr 115:e404\u2013411","journal-title":"Arch Argent Pediatr"},{"key":"2273_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaad.2021.03.050","volume":"85","author":"B King","year":"2021","unstructured":"King B, Guttman-Yassky E, Peeva E et al (2021) A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in Alopecia areata: 24-week results. J Am Acad Dermatol 85:379\u2013387","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2273_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jamadermatol.2024.2734","volume":"160","author":"B King","year":"2024","unstructured":"King B, Ko J, Kwon O, Va\u00f1\u00f3-Galv\u00e1n S, Piraccini BM, Dutronc Y, Yu G, Liu C, Somani N, Ball S, Mesinkovska NA (2024) Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial. JAMA Dermatol 160(10):1075\u20131081. https:\/\/doi.org\/10.1001\/jamadermatol.2024.2734","journal-title":"JAMA Dermatol"},{"key":"2273_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jaad.2022.03.045","volume":"87","author":"B King","year":"2022","unstructured":"King B, Mesinkovska N, Mirmirani P et al (2022) Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe Alopecia areata. J Am Acad Dermatol 87:306\u2013313","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR40","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","volume":"386","author":"B King","year":"2022","unstructured":"King B, Ohyama M, Kwon O et al (2022) Two phase 3 trials of baricitinib for Alopecia areata. N Engl J Med 386:1687\u20131699","journal-title":"N Engl J Med"},{"key":"2273_CR41","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/bjd\/ljad253","volume":"189","author":"B King","year":"2023","unstructured":"King B, Shapiro J, Ohyama M et al (2023) When to expect scalp hair regrowth during treatment of severe Alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials. Br J Dermatol 189:666\u2013673","journal-title":"Br J Dermatol"},{"key":"2273_CR42","first-page":"674","volume":"71","author":"EP Kubeyinje","year":"1994","unstructured":"Kubeyinje EP (1994) Intralesional triamcinolone acetonide in Alopecia areata amongst 62 Saudi Arabs. East Afr Med J 71:674\u2013675","journal-title":"East Afr Med J"},{"key":"2273_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0974-7753.66920","volume":"2","author":"M Kumaresan","year":"2010","unstructured":"Kumaresan M (2010) Intralesional steroids for Alopecia areata. Int J Trichology 2:63\u201365","journal-title":"Int J Trichology"},{"key":"2273_CR44","doi-asserted-by":"crossref","unstructured":"Kuo CM, Tung TH, Wang SH, Chi CC (2018)  Efficacy and safety of tofacitinib for moderate- to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol ; 32: 355\u2013362","DOI":"10.1111\/jdv.14695"},{"key":"2273_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","volume":"82","author":"HH Lee","year":"2020","unstructured":"Lee HH, Gwillim E, Patel KR et al (2020) Epidemiology of Alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol 82:675\u2013682","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR46","first-page":"5285","volume":"11","author":"X Lin","year":"2019","unstructured":"Lin X, Meng X, Song Z (2019) Vitamin D and Alopecia areata: possible roles in pathogenesis and potential implications for therapy. Am J Transl Res 11:5285\u20135300","journal-title":"Am J Transl Res"},{"key":"2273_CR47","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jaad.2018.11.037","volume":"80","author":"LY Liu","year":"2019","unstructured":"Liu LY, King BA (2019) Response to tofacitinib therapy of eyebrows and eyelashes in Alopecia areata. J Am Acad Dermatol 80:1778\u20131779","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/ijt.ijt_28_21","volume":"15","author":"K Malhotra","year":"2023","unstructured":"Malhotra K, Madke B (2023) An updated review on current treatment of Alopecia areata and newer therapeutic options. Int J Trichology 15:3\u201312","journal-title":"Int J Trichology"},{"key":"2273_CR49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1086\/511442","volume":"80","author":"A Martinez-Mir","year":"2007","unstructured":"Martinez-Mir A, Zlotogorski A, Gordon D et al (2007) Genomewide scan for linkage reveals evidence of several susceptibility loci for Alopecia areata. Am J Hum Genet 80:316\u2013328","journal-title":"Am J Hum Genet"},{"key":"2273_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00403-018-1876-y","volume":"311","author":"D Mikhaylov","year":"2019","unstructured":"Mikhaylov D, Pavel A, Yao C et al (2019) A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata. Arch Dermatol Res 311:29\u201336","journal-title":"Arch Dermatol Res"},{"key":"2273_CR51","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/ijms23031038","volume":"23","author":"Y Minokawa","year":"2022","unstructured":"Minokawa Y, Sawada Y, Nakamura M (2022) Lifestyle factors involved in the pathogenesis of Alopecia areata. Int J Mol Sci 23:1038","journal-title":"Int J Mol Sci"},{"key":"2273_CR52","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0190-9622(85)70088-6","volume":"12","author":"AJ Mitchell","year":"1985","unstructured":"Mitchell AJ, Douglass MC (1985) Topical photochemotherapy for Alopecia areata. J Am Acad Dermatol 12:644\u2013649","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archderm.1963.01590210048007","volume":"88","author":"SA Muller","year":"1963","unstructured":"Muller SA, Winkelmann RK (1963) Alopecia areata. An evaluation of 736 patients. Arch Dermatol 88:290\u2013297","journal-title":"Arch Dermatol"},{"key":"2273_CR54","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2353\/ajpath.2008.061249","volume":"172","author":"M Nakamura","year":"2008","unstructured":"Nakamura M, Jo J, Tabata Y, Ishikawa O (2008) Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H\/HeJ mouse model. Am J Pathol 172:650\u2013658","journal-title":"Am J Pathol"},{"key":"2273_CR55","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jaad.2019.10.016","volume":"82","author":"EA Olsen","year":"2020","unstructured":"Olsen EA, Kornacki D, Sun K, Hordinsky MK (2020) Ruxolitinib cream for the treatment of patients with Alopecia areata: a 2-part, double-blind, randomized, vehicle-controlled phase 2 study. J Am Acad Dermatol 82:412\u2013419","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR56","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1529-8019.2011.01420.x","volume":"24","author":"N Otberg","year":"2011","unstructured":"Otberg N (2011) Systemic treatment for Alopecia areata. Dermatol Ther 24:320\u2013325","journal-title":"Dermatol Ther"},{"issue":"Suppl 2","key":"2273_CR57","doi-asserted-by":"publisher","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","volume":"72","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea JJ, Kontzias A, Yamaoka K, Tanaka Y, Laurence A (2013) Janus kinase inhibitors in autoimmune diseases. Ann Rheum Dis 72(Suppl 2):ii111\u2013ii115","journal-title":"Ann Rheum Dis"},{"key":"2273_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000504786","volume":"6","author":"CT Pham","year":"2020","unstructured":"Pham CT, Romero K, Almohanna HM, Griggs J, Ahmed A, Tosti A (2020) The role of diet as an adjuvant treatment in scarring and nonscarring alopecia. Skin Appendage Disord 6:88\u201396","journal-title":"Skin Appendage Disord"},{"key":"2273_CR59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jaad.2018.06.064","volume":"80","author":"K Phan","year":"2019","unstructured":"Phan K, Ramachandran V, Sebaratnam DF (2019) Methotrexate for Alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 80:120\u2013127e2","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR60","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.15489","volume":"33","author":"K Phan","year":"2019","unstructured":"Phan K, Sebaratnam DF (2019) JAK inhibitors for Alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 33:850\u2013856","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2273_CR61","unstructured":"RCP banca dati AIFA Disponibile su: https:\/\/lc.cx\/A6CzVz [ultimo accesso 21 ottobre 2024]"},{"key":"2273_CR62","unstructured":"RCP banca dati AIFA Disponibile su: https:\/\/lc.cx\/A6CzVz [ultimo accesso 21 ottobre 2024]"},{"key":"2273_CR63","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","volume":"34","author":"Y Renert-Yuval","year":"2017","unstructured":"Renert-Yuval Y, Guttman-Yassky E (2017) The changing landscape of alopecia areata: the therapeutic paradigm. Adv Ther 34:1594\u20131609","journal-title":"Adv Ther"},{"key":"2273_CR64","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","volume":"39","author":"CK Rokhsar","year":"1998","unstructured":"Rokhsar CK, Shupack JL, Vafai JJ, Washenik K (1998) Efficacy of topical sensitizers in the treatment of Alopecia areata. J Am Acad Dermatol 39:751\u2013761","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR65","doi-asserted-by":"crossref","unstructured":"Senna MM, Mostaghimi A, Ohyama M et al Long-term efficacy of baricitinib in patients with severe Alopecia areata: week 52 results from BRAVE-AA1 and BRAVE- AA2. Poster presented at: American Academy of Dermatology (AAD); March 25\u201329, 2022.","DOI":"10.1016\/j.jaad.2022.06.243"},{"key":"2273_CR66","doi-asserted-by":"crossref","unstructured":"Seo HM, Kim TL, Kim JS (2018) The risk of Alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study. Sleep ; 41(9)","DOI":"10.1093\/sleep\/zsy111"},{"key":"2273_CR67","doi-asserted-by":"publisher","first-page":"117ra9","DOI":"10.1126\/scitranslmed.3003041","volume":"4","author":"M Shan","year":"2012","unstructured":"Shan M, Yuan X, Song LZ et al (2012) Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 4:117ra9","journal-title":"Sci Transl Med"},{"key":"2273_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/12034754231168839","volume":"27","author":"C Sibbald","year":"2023","unstructured":"Sibbald C (2023) Alopecia areata: an updated review for 2023. J Cutan Med Surg 27:241\u2013259","journal-title":"J Cutan Med Surg"},{"key":"2273_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.12437","volume":"30","author":"MA El Taieb","year":"2017","unstructured":"El Taieb MA, Ibrahim H, Nada EA, Seif Al-Din M (2017) Platelets rich plasma versus minoxidil 5% in treatment of Alopecia areata: a trichoscopic evaluation. Dermatol Ther 30:1\u20136","journal-title":"Dermatol Ther"},{"key":"2273_CR70","doi-asserted-by":"publisher","first-page":"9e1","DOI":"10.1016\/j.jaad.2009.02.037","volume":"61","author":"R Talpur","year":"2009","unstructured":"Talpur R, Vu J, Bassett R, Stevens V, Duvic M (2009) Phase I\/II randomized bilateral half- head comparison of topical bexarotene 1% gel for Alopecia areata. J Am Acad Dermatol 61:9e1\u20139e9","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1525-1470.2002.00088.x","volume":"19","author":"E Tan","year":"2002","unstructured":"Tan E, Tay YK, Giam YC (2002) A clinical study of childhood Alopecia areata in Singapore. Pediatr Dermatol 19:298\u2013301","journal-title":"Pediatr Dermatol"},{"key":"2273_CR72","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.0906-6705.2004.00098.x","volume":"13","author":"L Tang","year":"2004","unstructured":"Tang L, Cao L, Sundberg JP, Lui H, Shapiro J (2004) Restoration of hair growth in mice with an Alopecia areata-like disease using topical anthralin. Exp Dermatol 13:5\u201310","journal-title":"Exp Dermatol"},{"key":"2273_CR73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1067\/mjd.2003.423","volume":"49","author":"A Tosti","year":"2003","unstructured":"Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C (2003) Clobetasol propionate 0.05% under occlusion in the treatment of Alopecia totalis\/universalis. J Am Acad Dermatol 49:96\u201398","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR74","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2147\/DDDT.S172638","volume":"12","author":"K Triyangkulsri","year":"2018","unstructured":"Triyangkulsri K, Suchonwanit P (2018) Role of Janus kinase inhibitors in the treatment of Alopecia areata. Drug Des Devel Ther 12:2323\u20132335","journal-title":"Drug Des Devel Ther"},{"key":"2273_CR75","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jaad.2017.07.051","volume":"78","author":"TY Tsai","year":"2018","unstructured":"Tsai TY, Huang YC (2018) Vitamin D deficiency in patients with Alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 78:207\u2013209","journal-title":"J Am Acad Dermatol"},{"key":"2273_CR76","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2340\/00015555-3183","volume":"99","author":"H Uchida","year":"2019","unstructured":"Uchida H, Kamata M, Watanabe A et al (2019) Dupilumab improved Alopecia areata in a patient with atopic dermatitis: a case report. Acta Derm Venereol 99:675\u2013676","journal-title":"Acta Derm Venereol"},{"key":"2273_CR77","first-page":"327","volume":"63","author":"W Veith","year":"2011","unstructured":"Veith W, Deleo V, Silverberg N (2011) Medical phototherapy in childhood skin diseases. Minerva Pediatr 63:327\u2013333","journal-title":"Minerva Pediatr"},{"key":"2273_CR78","first-page":"641","volume":"46","author":"WK Wong","year":"2008","unstructured":"Wong WK, Shin JH, Choi GS (2008) Therapeutic effect of topical anthralin for treatment- resistant extensive Alopecia areata. Korean J Dermatol 46:641\u2013647","journal-title":"Korean J Dermatol"},{"key":"2273_CR79","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing L, Dai Z, Jabbari A et al (2014) Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 20:1043\u20131049","journal-title":"Nat Med"},{"key":"2273_CR80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","volume":"61","author":"C Zhou","year":"2021","unstructured":"Zhou C, Li X, Wang C, Zhang J (2021) Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol 61:403\u2013423","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02273-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02273-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02273-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:59Z","timestamp":1781701439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02273-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02273-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors consent to the publication of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The opinions expressed in this manuscript are solely those of the author and do not represent the official policy or position of the administrative institutions to which they are affiliated.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}